Back
Corcept Therapeutics Stock Predictions
Buy
81
CORT
Corcept Therapeutics
Last Price:
27.54
Seasonality Move:
8.36%
7 Day Trial
ALL ACCESS PASS
$
7
Corcept Therapeutics Stock Forecast
- Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 33.1% based on the past 20 years of stock performance.
- Corcept Therapeutics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
-
Is Corcept Therapeutics Stock Undervalued?
The current Corcept Therapeutics [CORT] share price is $27.83. The Score for CORT is 81, which is 62% above its historic median score of 50, and infers lower risk than normal. - CORT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
Will Corcept Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 33.1% based on the past 20 years of stock performance.
Corcept Therapeutics Stock Rating
Buy
81
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics overpriced?
- Corcept Therapeutics has risen higher in 11 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 55%
Corcept Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com
52-Week Data
52-Week High:
34.28
52-Week Low:
20.84
Prediction Charts
Market Cap:
2.9B
Price in USD:
27.83
Volume:
682.54K
Beta:
0.83
Technical Analysis
SMA50:
24.36
SMA100:
24.43
SMA200:
26.67
52-Wk Change:
15.67%
Stock Predictions
-
Is Corcept Therapeutics stock public?
Yes, Corcept Therapeutics is a publicly traded company. -
What is the Corcept Therapeutics stock quote today?
The Corcept Therapeutics stock price is 27.83 USD today. -
How to buy Corcept Therapeutics stock online?
You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-26 | 22.28 | 22.80 | 23.22 | 22.28 |
Apr-29 | 23.03 | 23.37 | 23.58 | 22.79 |
Apr-30 | 23.47 | 23.33 | 23.94 | 23.29 |
May-1 | 23.09 | 23.88 | 24.61 | 22.60 |
May-2 | 26.39 | 25.08 | 26.39 | 23.80 |
May-3 | 25.06 | 24.52 | 25.22 | 23.11 |
May-6 | 24.52 | 23.97 | 24.58 | 23.02 |
May-7 | 24.17 | 24.48 | 24.62 | 23.61 |
May-8 | 24.26 | 25.40 | 25.54 | 23.90 |
May-9 | 25.49 | 26.62 | 26.62 | 25.35 |
May-10 | 26.83 | 27.04 | 27.48 | 26.53 |
May-13 | 27.35 | 27.53 | 29.27 | 27.23 |
May-14 | 27.87 | 27.66 | 28.18 | 26.87 |
May-15 | 28.12 | 27.83 | 28.46 | 27.63 |
Corcept Therapeutics Earnings
Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corcept Therapeutics Forecast Revenue Growth
Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.02 per share, an increase this year of $0.08 per share, and an increase next year of $0.05 per share.
* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.